Particle.news
Charged Particles Fusion Energy Magnetohydrodynamics Solar Plasma Fusion Reactions Nuclear Fusion Fusion Research Solar Wind Coronal Mass Ejections Solar Physics Nuclear Physics Solar Activity Solar Phenomena Solar Flares Ionosphere Space Plasma Solar Dynamics Magnetized Plasma Astrophysical Jets Radiation Belts Auroras Magnetic Fields Fusion Reactors Fusion Plasma Magnetic Confinement Astrophysical Plasma X-ray Generation X-ray Pulses Magnetosphere Laboratory Experiments Interstellar Medium Plasma Instruments Solar Outbursts Wave Optics Ionized Particles Solar Particles Tokamak Devices Fusion Processes Kinetic Theory Collisionless Shocks Inertial Confinement Fusion Charged Gases Electrons Dynamo Theory Electric Discharges Space Weather Accretion Disks Pulsed Power Computational Physics Cosmic Rays Magnetospheres Alfvén Waves Magnetic Reconnection Tokamak Coronal Heating Gaseous Mixtures Solar Magnetic Field Superheated Plasma Fusable Plasmas Medical Applications of Plasma Plasma Instability Plasma State Dynamics of Plasma Electron-Positron Pairs Plasma Flow Fusion Tokamaks Neutral Particles Stability Geomagnetic Storms High-Temperature Plasma Hot Plasma Tokamak Systems Magnetic Islands Plasma Diagnostics Wave Dynamics Fusion Physics Tokamak Reactor Wave Phenomena Ionospheric Physics Instabilities Quantum Interactions Ions Ionized Plasma High-Energy Astrophysics
Researchers at Osaka Metropolitan University report significant tumor reduction in preclinical studies using a novel plasma-based therapy with no observed toxicity.
